Nature S Sunshine Products Inc Revenue per Employee (NATR), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nature s Sunshine Products inc   (NASDAQ: NATR)
 

Nature S Sunshine Products Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 2.35% in the second quarter 2026, year on year to cumulative value of $492 million, Nature S Sunshine Products Inc 's revenue per employee grew on a trailing twelve months basis to $ 610,161, this marks a new company high.
Within the Healthcare sector Employees of 142 other companies have achieved higher revenue per employee. While Nature S Sunshine Products Inc 's total ranking has deteriorated compared to the previous quarter from 1104 to 1360. Nature S Sunshine Products Inc has 806 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NATR Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 2.35 % 8.33 % 4.8 % 12.56 % 4.02 %
Sales per Employee (TTM) $ 610,161 606,829 595,191 588,101 570,371
NATR's Total Ranking # 1360 # 1104 # 1198 # 753 # 499
Seq. Revenue Change -4.09 % -2.25 % -2.55 % 12.03 % 1.51 %

NATR Company Profile >> Back to NATR Efficiency Comparisons >> Compare NATR Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 92
Healthcare Sector # 143
Overall Market # 1360

Revenue per Employee Statistics
High Average Low
$ 610,161 $ 486,199 $ 401,029
(Jun 30 2026)   (Mar 31 2016)



Financial Statements
Nature S Sunshine Products Inc 's Revenue MRQ $ 117 Millions Visit NATR's Income Statement
Nature S Sunshine Products Inc 's Revenues TTM $ 492 Millions Visit NATR's aggregate revenue growth
What are NATR's Sales? Visit NATR's Sales by Segment




Other Ratios
Nature S Sunshine Products Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
NATR's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for NATR's Competitors
Revenue per Employee for NATR's Suppliers
Revenue per Employee for NATR's Customers

You may also want to know
NATR's Sales Growth Rates NATR's Pe Price to earnings ratio NATR's Receivables Turnover Ratio NATR's Stock Quote
NATR's Net Income Growth Rates NATR's Ps Price to Sales ratio NATR's Sales per Employee NATR's Asset Turnover Ratio
NATR's Net Margin NATR's Pb Price to Book ratio NATR's Financial Strength Ratios NATR's Dividend Payout Ratio
Date modified: 2026-09-05T15:20:42+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Biomarin Pharmaceutical Inc  1,057,626.20 $ 3,406.614  Million 3,221 
Hims and Hers Health Inc   1,055,894.35 $ 2,578.494  Million 2,442 
Assembly Biosciences Inc   1,025,273.97 $ 74.845  Million 73 
Sanara Medtech Inc   1,019,592.91 $ 110.116  Million 108 
Ani Pharmaceuticals Inc  1,008,638.14 $ 978.379  Million 970 
Coya Therapeutics Inc   1,002,393.13 $ 8.019  Million 8 
Meiragtx Holdings Plc  986,354.84 $ 397.501  Million 403 
Arrowhead Pharmaceuticals Inc   941,624.47 $ 669.495  Million 711 
Scilex Holding Company  929,647.06 $ 31.608  Million 34 
The Oncology Institute Inc   916,137.29 $ 587.244  Million 641 
Pacira Biosciences inc   900,077.20 $ 746.164  Million 829 
Fortress Biotech Inc   897,217.95 $ 69.983  Million 78 
Alphatec Holdings Inc   892,420.59 $ 814.780  Million 913 
Merck and Co Inc   887,586.67 $ 66,569.000  Million 75,000 
Nektar Therapeutics  866,492.06 $ 54.589  Million 63 
Bridgebio Pharma Inc   849,903.46 $ 713.069  Million 839 
Pfizer Inc  849,280.00 $ 63,696.000  Million 75,000 
Syndax Pharmaceuticals Inc   845,651.01 $ 252.004  Million 298 
Xilio Therapeutics Inc   843,315.79 $ 64.092  Million 76 
Axsome Therapeutics Inc   839,534.05 $ 776.569  Million 925 
Ionis Pharmaceuticals Inc   834,107.70 $ 1,169.419  Million 1,402 
Immunocore Holdings Plc  822,089.69 $ 430.775  Million 524 
Alkermes Plc   813,488.78 $ 1,667.652  Million 2,050 
Lifevantage Corp  811,421.52 $ 180.947  Million 223 
Sanuwave Health Inc   798,236.36 $ 43.903  Million 55 
Septerna Inc   760,630.77 $ 98.882  Million 130 
Dyadic International Inc   760,447.40 $ 3.802  Million 5 
Transmedics Group Inc   744,396.44 $ 668.468  Million 898 
Aveanna Healthcare Holdings Inc   743,662.86 $ 2,602.820  Million 3,500 
Veracyte Inc   721,503.31 $ 544.735  Million 755 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.